ANO1‐Mediated Ferroptosis Inhibition Provokes TGF‐β Production and Release and Recruits Cancer‐Associated Fibroblasts into TIME, Generating Resistance to Immunotherapy. This evidence concerns the gene ANO1 and cancer.